rs796052455

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BS2BS1BP5_Strong

This summary comes from the ClinGen Evidence Repository: The highest population minor allele frequency of the p.Gly126Ser variant in FOXG1 in gnomAD v4.1 is 0.0001782 in European (non-Finnish) population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.00008) for BS1, and therefore meets this criterion (BS1). The p.Gly126Ser variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Gly126Ser variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_Strong). In summary, the p.Gly126Ser variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BS1, BS2, BP5_Strong). LINK:https://erepo.genome.network/evrepo/ui/classification/CA314582/MONDO:0100040/035

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 missense

Scores

2
1
16

Clinical Significance

Benign reviewed by expert panel U:1B:5

Conservation

PhyloP100: 1.92
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP5
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXG1NM_005249.5 linkc.376G>A p.Gly126Ser missense_variant Exon 1 of 1 ENST00000313071.7 NP_005240.3 P55316

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXG1ENST00000313071.7 linkc.376G>A p.Gly126Ser missense_variant Exon 1 of 1 6 NM_005249.5 ENSP00000339004.3 P55316
FOXG1ENST00000706482.1 linkc.376G>A p.Gly126Ser missense_variant Exon 2 of 2 ENSP00000516406.1 P55316
LINC01551ENST00000675861.1 linkn.374+1642G>A intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0000726
AC:
11
AN:
151430
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000525
AC:
4
AN:
76180
Hom.:
0
AF XY:
0.0000760
AC XY:
3
AN XY:
39458
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000148
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000152
AC:
200
AN:
1318346
Hom.:
0
Cov.:
33
AF XY:
0.000138
AC XY:
89
AN XY:
644244
show subpopulations
Gnomad4 AFR exome
AF:
0.0000338
Gnomad4 AMR exome
AF:
0.0000368
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000180
Gnomad4 OTH exome
AF:
0.000164
GnomAD4 genome
AF:
0.0000660
AC:
10
AN:
151524
Hom.:
0
Cov.:
31
AF XY:
0.0000405
AC XY:
3
AN XY:
74044
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000148
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

FOXG1: PP2 -

Dec 14, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Aug 05, 2016
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Oct 09, 2017
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FOXG1 disorder Benign:1
Aug 30, 2024
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The highest population minor allele frequency of the p.Gly126Ser variant in FOXG1 in gnomAD v4.1 is 0.0001782 in European (non-Finnish) population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.00008) for BS1, and therefore meets this criterion (BS1). The p.Gly126Ser variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Gly126Ser variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_Strong). In summary, the p.Gly126Ser variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BS1, BS2, BP5_Strong). -

Rett syndrome, congenital variant Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.57
T
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.69
N
REVEL
Benign
0.024
Sift
Benign
0.23
T
Sift4G
Benign
0.68
T
Polyphen
0.018
B
Vest4
0.062
MVP
0.061
ClinPred
0.044
T
GERP RS
1.9
Varity_R
0.089
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs796052455; hg19: chr14-29236861; API